US Patent Issued to Fresenius Medical Care Holdings on May 12 for "Compounds, systems, and techniques for removal of peripheral amyloid beta peptide with albumin binding competitors" (Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,623,013, issued on May 12, was assigned to Fresenius Medical Care Holdings Inc. (Waltham, Mass.).

"Compounds, systems, and techniques for removal of peripheral amyloid beta peptide with albumin binding competitors" was invented by Xia Tao (Waltham, Mass.), Peter Kotanko (Waltham, Mass.), Stephan Thijssen (Waltham, Mass.) and Vaibhav Maheshwari (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds, systems, kits, methods, and/or apparatuses may be operative to reduce amyloid beta (ABeta) peptide in a patient, including a central nervous system (CNS) of the patient and/or a periphery (non-CNS portion) of the patient. In some embodiments,...